Brain Transplant
(NOVA, 12/15/1992, copyright PBS)
- the two most common degenerative diseases of aging
- Parkinson's disease
- symptoms (signs)
- resting tremor
- slowness (poverty) of movement
- cogwheel rigidity
- slow, shuffling gait
- loss of facial expression (masked face)
- l-dopa therapy has been most successful but has side effects (concept of the "therapeutic window")
- uncontrollable movements (athetosis)
- hallucinations
- Alzheimer's disease
- cell transplants
- adrenal cell transplants done in Mexico were claimed to alleviate Parkinson's disease, but this result could not be replicated elsewhere
- fetal cell (substantia nigra) transplants in monkeys reversed MPTP parkinsonism
- research in Sweden indicated that fetal cell transplants might be the only hope for patients with degenerative diseases such as Parkinson's and Alzheimer's disease
- strict ethical guidelines were established for operations in humans
- initial results were disappointing in older debilitated patients, so they decided to try a transplant in a younger patient with MPTP parkinsonism - after extensive screening, two candidates were chosen who were not so severely impaired that they could not be pretested
- fetal tissure grafts
- fetal tissue must be young - 6 to 8 weeks post fertilization
- tissue is implanted into the caudate nucleus and putamen
- the operation is carried out in two stages for implants on each side of the brain
- there was not much improvement after a year (in George's case), but by two years there was a dramatic improvement (although not complete recovery)
- PET scanning showed substantial recovery of dopamine in the basal ganglia, even though only 10% of the transplanted cells survived
- neuroprotection may be necessary in older patients with idiopathic parkinsonism to prevent the grafted cells from being killed off by the on-going disease process
Return to PSYC 415 Main Page